Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 3.0 S - 11 mm: medical device reports filed with FDA

1,346 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

1,346
device reports naming the brand
0% of all MAUDE reports · about 190 a year
194
reports, 12 months to August 2026
236 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,346 reports that name the brand "OsseoSpeed TX 3.0 S - 11 mm" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

194 reports arrived in the 12 months to August 2026, down 18% from 236 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (52.5%), osseointegration problem (28.5%) and loss of osseointegration (18.6%). The patient problems coded most often are failure of implant, inflammation and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01938Sep 2021: 12Oct 2021: 12Nov 2021: 21Dec 2021: 192022Jan 2022: 14Feb 2022: 8Mar 2022: 16Apr 2022: 14May 2022: 5Jun 2022: 9Jul 2022: 10Aug 2022: 29Sep 2022: 10Oct 2022: 11Nov 2022: 17Dec 2022: 182023Jan 2023: 8Feb 2023: 14Mar 2023: 13Apr 2023: 13May 2023: 7Jun 2023: 17Jul 2023: 19Aug 2023: 22Sep 2023: 18Oct 2023: 19Nov 2023: 12Dec 2023: 202024Jan 2024: 19Feb 2024: 19Mar 2024: 25Apr 2024: 38May 2024: 26Jun 2024: 22Jul 2024: 34Aug 2024: 33Sep 2024: 32Oct 2024: 28Nov 2024: 9Dec 2024: 152025Jan 2025: 29Feb 2025: 9Mar 2025: 26Apr 2025: 6May 2025: 7Jun 2025: 16Jul 2025: 33Aug 2025: 26Sep 2025: 18Oct 2025: 11Nov 2025: 10Dec 2025: 52026Jan 2026: 25Feb 2026: 10Mar 2026: 19Apr 2026: 20May 2026: 17Jun 2026: 22Jul 2026: 23Aug 2026: 14

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01723442019: 1320192021: 34420212022: 16120222023: 18220232024: 30020242025: 19620252026: 1502026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,346
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,346
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate70652.5%62.8%
Osseointegration problem38328.5%7.7%
Loss of osseointegration25118.6%22.4%
Off-label use1259.3%0%
Fracturea broken bone90.7%1.6%
Loosening of implant not related to bone-ingrowth60.4%0.1%
Insufficient device problem information20.1%0.2%
Crackthe device cracked10.1%0%
Damaged thread10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,346100%
Inflammationinflammation14310.6%
Pocket erosion725.3%
Osteolysis463.4%
Inadequate osseointegration30.2%
Implant pain20.1%
Abscessa collection of pus10.1%
Osteopenia/ osteoporosis10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 3.0 S - 11 mmProduct code DZEAll MAUDE reports
Reports1,3463,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 3.0 S - 11 mm reports

How many FDA reports name OsseoSpeed TX 3.0 S - 11 mm?

1,346 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 194 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (52.5%), osseointegration problem (28.5%), loss of osseointegration (18.6%), off-label use (9.3%) and fracture (0.7%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 3.0 S - 11 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.